Literature DB >> 17574244

Toxocara canis: molecular cloning, characterization, expression and comparison of the kinetics of cDNA-derived arginine kinase.

Susiji Wickramasinghe1, Kouji Uda, Mitsuru Nagataki, Lalani Yatawara, R P V J Rajapakse, Yoshiya Watanabe, Tomohiko Suzuki, Takeshi Agatsuma.   

Abstract

Arginine kinase (AK) is a member of a highly conserved family of phosphagen kinases. We determined the cDNA sequence of Toxocara canis AK, cloned it in pMAL plasmid and expressed it in Escherichia coli as a fusion protein with maltose-binding protein. The protein has a theoretical molecular mass of 45,376 Da and an estimated isoelectric point (pI) of 8.38. Alignment of the cDNA-derived amino acid sequence of T. canis AK with other phosphagen kinase sequences showed high amino acid identity with other nematode AKs, and phylogenetic analysis placed it as a distinct branch within a nematode AK cluster. Analysis of the N-terminus sequence of T. canis AK revealed the presence of a signal targeting peptide presumably targeting this protein to cytosol or endoplasmic reticulum (ER). T. canis AK showed high activity for l-arginine. The kinetic constants (K(m) = 0.12 mM, K(cat) = 29.18, and K(d) = 0.23 mM) and V(max) (43.76 micromolPi/min/mg protein) of T. canis recombinant-AK were determined for the forward reaction. It also exhibited a synergism for substrate binding (K(d)(Arg)/K(m)(Arg)=1.96). Comparison of K(cat)/K(m)(Arg) values in various arginine kinases indicates that T. canis AK has a high catalytic efficiency (248.19s(-1)mM(-1)). The present study contains the first description of arginine kinase in a zoonotic nematode. The determination of T. canis AK and its phosphagen biosynthetic pathway, which is completely different from those in mammalian host tissues, suggests this enzyme as a possible novel chemotherapy target for VLM syndrome in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574244     DOI: 10.1016/j.exppara.2007.03.015

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

1.  Immunolocalization of arginine kinase (AK) in Toxocara canis, Toxocara vitulorum, and Ascaris lumbricoides.

Authors:  D G R S Kulathunga; Susiji Wickramasinghe; R P V J Rajapakse; Lalani Yatawara; W R Jayaweera; Takeshi Agatsuma
Journal:  Parasitol Res       Date:  2012-03-08       Impact factor: 2.289

2.  Molecular cloning and characterization of arginine kinase gene of Toxocara canis.

Authors:  Shivani Sahu; S Samanta; D R Harish; N R Sudhakar; O K Raina; S B Shantaveer; D N Madhu; Ashok Kumar
Journal:  J Parasit Dis       Date:  2013-06-19

3.  Development of a highly sensitive IgG-ELISA based on recombinant arginine kinase of Toxocara canis for serodiagnosis of visceral larva migrans in the murine model.

Authors:  Susiji Wickramasinghe; Lalani Yatawara; Mitsuru Nagataki; Misa Takamoto; Yoshiya Watanabe; R P V J Rajapakse; Kouji Uda; Tomohiko Suzuki; Takeshi Agatsuma
Journal:  Parasitol Res       Date:  2008-06-25       Impact factor: 2.289

Review 4.  Phosphagen kinases of parasites: unexplored chemotherapeutic targets.

Authors:  Blanca R Jarilla; Takeshi Agatsuma
Journal:  Korean J Parasitol       Date:  2010-12-16       Impact factor: 1.341

5.  Molecular cloning and characterization of taurocyamine kinase from Clonorchis sinensis: a candidate chemotherapeutic target.

Authors:  Jing-Ying Xiao; Ji-Yun Lee; Shinji Tokuhiro; Mitsuru Nagataki; Blanca R Jarilla; Haruka Nomura; Tae Im Kim; Sung-Jong Hong; Takeshi Agatsuma
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.